Abstract:Objective: This article focused on the synthesis and characterization of heterocyclic compounds containing two heteroatoms, as well as computational investigations, the acetylcholinesterase enzyme assay, and antioxidant properties. Methods: in this article, we conducted multicomponent reactions and these reactions were based on the condensation method. The DPPH method was used to determine antioxidant activity results. Results: The present study includes the synthesis of 3-{[(1-H-benzimidazole-2-yl)sulfanyl](heterocarbaldehyde)methyl}4-hydroxy-2- H -benzopyran-2-one derivatives by the one-pot multicomponent reaction and further structures were characterized by various analytical techniques. Discussion: Design and synthesis of coumarin derivatives and confirmed by different spectroscopic techniques DFT calculations at B3YLP/6-311+G(d,p) were used to perform geometry optimization on the coumarin derivatives. MEP provides a visual method for understanding a molecule's reactivity. In Acetylcholinesterase inhibitory assay, the HeLa cell line is treated with synthesized compounds and compounds show promising activity. Additionally, the 3D representation of all derivatives' interactions with proteins and ligands as well as the active site of ligands on receptor surfaces. Conclusions: A novel series of coumarinbenzimidazole compounds was successfully developed and synthesized. Among all, compound ( IVa ) demonstrates good inhibition against Hela cancer cell lines, which is corroborated by in silico docking studies in which ( IVa ) compound has a good binding affinity of –10.1 kcl/mol, indicating the best binding interactions with the receptor when compared to the target molecules.

Bio-rational Design of Photosystem II Inhibitors (VIII)

Biorational design, synthesis, and inhibition of photosystem II inhibitors

Studies on bio-rational design of photosystem II inhibitors ( II ) - The crystal and molecular structure of ethyl 3-benzylamino-2-cyano-3-methylthioacrylate

Studies on bio-rational design of photosystem II inhibitors ( V ) - Synthesis and hill inhibitory activities of ethyl arylamideacrylates and pyrimidone

Studies on bio-rational design of photosystem II inhibitors (III) - Comparative molecular field analysis of 3-(4-chlorobenzylamino)-2-cyano-3-alkylacrylate inhibitors

Studies on Bio-rational design of photosystem II inhibitors ( III ) - Comparative molecular field analysis of 3-(4-chlorobenzylamino)-2-cyano-3-alkylacryl ate inhibitors

Bio-Rational Design Synthesis of Novel Herbicides

Binding Model And 3d-Qsar Of 3-(2-Chloropyrid-5-Ylmethylamino)-2-Cyanoacrylates As Psii Electron Transport Inhibitor

Synthesis of Novel Derivatives of 2-Cyano-3-methylthio-3 '-Benzylamino Acrylates(Acrylamides) and Their Biological Activity

[Synthesis and AchE Inhibitory Activity of 2-Phenoxy-indan-1-one Derivatives].

Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.

Biososteric Replacement in the Design and Synthesis of Ligands for Nicotinic Acetylcholine Receptors

Synthesis, Biological Evaluation and Molecular Docking Studies of 3-(1,3-diphenyl-1h-pyrazol-4-yl)-n-phenylacrylamide Derivatives As Inhibitors of HDAC Activity.

Design, Synthesis and Biological Activity Evaluation of Novel Covalent S -Acylation Inhibitors

Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitors

A Series of Novel 1- H-isoindole-1,3(2 H)-dione Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: In Silico, Synthesis and In Vitro Studies

Studies on the synthesis of 2H-pyran-2-one compounds and their biological activities

Acetylcholine Inhibitory Study of Novel Thio Linked Coumarin-Benzimidazole Derivatives: Design, Synthesis, Computational, and In Silico Molecular Docking Studies

Design, Synthesis, and Acaricidal Activity of 2,5-Diphenyl-1,3-oxazoline Compounds

Design, Synthesis, and Analysis of the Quantitative Structure-Activity Relationships of 4-Phenyl-acyl-substituted 3-(2,5-dimethylphenyl)-4-hydroxy-1-azaspiro[4.5]dec-3-ene-2,8-dione Derivatives

Design, Synthesis, and Bioactivity of Novel 2-(Arylformyl)cyclohexane-1,3-dione Derivatives as HPPD Inhibitors